Eagle Bay Advisors LLC Supernus Pharmaceuticals, Inc. Transaction History
Eagle Bay Advisors LLC
- $170 Million
- Q3 2024
A detailed history of Eagle Bay Advisors LLC transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Eagle Bay Advisors LLC holds 149 shares of SUPN stock, worth $5,337. This represents 0.0% of its overall portfolio holdings.
Number of Shares
149
Previous 229
34.93%
Holding current value
$5,337
Previous $6,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding SUPN
# of Institutions
282Shares Held
60.9MCall Options Held
27.7KPut Options Held
11.3K-
Black Rock Inc. New York, NY10.4MShares$372 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.13MShares$220 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.1MShares$183 Million2.64% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.88MShares$103 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C32.63MShares$94.3 Million0.09% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $1.92B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...